When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. Our
7th Drug Formulation, Solubility & Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success. This event provides you with an unmatched focus on the latest technologies and team skills that you need to gather and interpret first-in-human results and accelerate time-to-market.
Top Five Reasons to Attend
- Breakthroughs in oral biologics delivery
- Deeper understanding of self-association to enhance formulation performance
- Strategies to design, interpret and rank the performance of the next generation of predictive models
- Skills for getting long-term stability answers in the shortest time possible
- Latest insights on 3D printing applications for enabled formulations
Speakers
- Rossitza Alargova, Director, Formulations, INFINITY PHARMACEUTICALS
- Gail Dempsey, EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH
- Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety, MEDIMMUNE
- Emilija Fredro-Kumbaradzi, Manager, Biowaivers and Biocorrelations, APOTEX
- Ruchi Gupta, Scientist, MEDIMMUNE
- Joachim Hoechel, Head, Clinical Pharmacology, BAYER
- Keith Horspool, Vice President, Pharmaceutics, BOEHRINGER INGELHEIM
- James Huckle, Scientist, Basic Pharmaceutics, Oral Delivery Product and Process Development, AMGEN
- Fady Ibrahim, Principal Scientist, Biopharmaceutics, PFIZER
- Neera Jain, Senior Director, CMC, SYROS PHARMACEUTICALS
- Wen Lin, Senior Investigator, NOVARTIS
- Eric Munson, Professor, Pharmaceutical Technology, UNIVERSITY OF KENTUCKY
- Karthik Nagapudi, Senior Scientist, GENENTECH
- Robert Prud’homme, Professor, Chemical and Biological Engineering, PRINCETON UNIVERSITY
- Fenghe Qiu, Senior Research Fellow, BOEHRINGER INGELHEIM
- Robert Saklatvala, Director, Basic Pharmaceutical Sciences, MERCK
- Manuel Sanchez-Felix, Senior Fellow, Formulations, NOVARTIS
- Jaymin Shah, Research Fellow, Pharmaceutical Sciences, Parenteral Development Centre of Emphasis, PFIZER
- Pavithra Sundararajan, Assistant Principal Scientist, Preclinical Development, MERCK
- Meena Venugopal, Vice President, Biopharmaceutics, ALVOGEN
- Dedong Wu, Senior Scientist, ASTRAZENECA
- Liping Zhou, Head, Formulation Development, RA PHARMACEUTICALS
- Andy Zhu, Head, Preclinical Oncology Modeling and Simulations, TAKEDA
Please fill in your name and email to receive the conference agenda of this event.
Advances in Drug Delivery Seminar - Monday, March 26, 2018
Conference Day One - Tuesday, March 27, 2018
Conference Day Two - Wednesday, March 28, 2018
The agenda is available as PDF under downloads at the right side of the page.
Venue
Revere Hotel Boston Common
200 Stuart St, 02116
Boston, MA, USA
Who Should Attend
This event is designed for pharmaceutical, biotech and medical device professionals responsible for the following areas:
- Formulation / Preformulation
- Pharmaceutical Development
- Preclinical Development
- Pharmacokinetics / Pharmacodynamics / PKDM / DMPK
- Solubility
- Pharmaceutics / Biopharmaceutics
- R&D / Process R&D
- Physicochemistry
- Solid State
- Drug Delivery
- Drug Discovery
- Analytical Development / Analytical Chemistry
- Pharmacometrics
- Manufacturing Technology / CMC
- Medicinal Chemistry
- Clinical Pharmacology
- Material Science
- Toxicology
- Chemical Engineering
- Correlation / Biocorrelation
- Modification
This event is also of interest to:
- Formulation Specialists
- Drug Delivery Specialists
- Excipient Manufacturers / Suppliers
- CROs
Venue
Revere Hotel Boston Common200 Stuart Street
Boston, MA 02116
To make reservations over the phone, please call 1-855-673-8373 and request the negotiated rate for “ExL’s 7th Bioavailability.”
To make reservations online
Click HereYou must book your room by March 5, 2018, in order to receive the group rate. Please book your room early, as rooms available at this rate are limited.
